Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival. 1992

G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
Medizinische Klinik, Universitätsklinikum Steglitz, Berlin, Germany.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human

Related Publications

G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
December 1992, Transplantation proceedings,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
October 2020, Transplant immunology,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
December 1990, Journal of immunology (Baltimore, Md. : 1950),
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
September 2000, Transplantation,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
September 1981, Transplantation,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
January 1985, Transplantation,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
December 2019, Human immunology,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
June 1983, Transplantation,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
September 1994, The New England journal of medicine,
G Offermann, and S Bünte, and U Angelides, and U Geidner, and B Kirschbaum, and E Müller, and N Wendt
December 1993, Transplantation proceedings,
Copied contents to your clipboard!